Employing the European Thyroid Imaging Reporting and Data System 2017 classification in a malignancy risk stratification system for thyroid nodules at Can Tho Oncology Hospital from 2021 to 2023

Vo Van Kha; Tran Thi Huong Ly; Pham Thi Thanh Hoa; Vo Huynh Nhu; Damas Hendriansyah; Nusratuddin Abdullah; Rudy B. Leonardy; Mardiah Tahir; Samrichard Rambulangi; Firdaus Hamid; Filomena Pietrantonio; Vera Kopsaj; Francesco Rosiello; Aurora Tomassoni; Luca Moriconi; Donatella Padua; Kiki Rizki Amelia; Efendi Lukas; Nurbani Bangsawan; Isharyah Sunarno; Retno Budiarti Farid; Sriwijaya Qadar; Rabab H. Elshaikh; Ashok Kumar Sah; Abdelrahman Mohamed Abukanna; Abdulrahman Algarni; Ammar Abdelmola; Hussam Ali Osman; Tagwa Yousif Elsayed Yousif; Elryah I. Ali; Hiba Ali; Ayman Hussein Alfeel; Thanh Long Nguyen; Victor Storm; Lam Toi Phung; Cong Thien Le; Thi Thu Ha Le; Thi Hoa Nguyen; Son Tung Vu; Thien Thang Tran; Minh Hanh Vu; Van Tuan Nguyen; Francesco Ventrella; Anna Belfiore; Antonio Greco; Franco Mastroianni; Salvatore Lenti; Domenico Ruggiero; Michele Cannone; Vincenzo Ostilio Palmieri; Massimo Errico; Giuseppe Mancia; Guido Grassi; Sverre E. Kjeldsen

doi:10.4081/itjm.2025.1852

Search

Search Results

##search.searchResults.foundPlural##

Sex-gender and atrial fibrillation treatment in the AntiThrombotic Agents in Atrial Fibrillation (ATA-AF) study

Cecilia Politi, Tiziana Ciarambino, Letizia Riva, Stefania Frasson, Donata Lucci, Gualberto Gussoni, Lucio Gonzini, Mauro Campanini, Michele Gulizia, Giuseppe Di Pasquale, Giovanni Mathieu, on behalf of ATA-AF Steering Committee and Investigators

207-212

16-02-2016

https://doi.org/10.4081/itjm.2016.649

1997

PDF: 1589

Appendix: 782

HTML: 550
Old and new oral anticoagulants for secondary stroke prevention in atrial fibrillation

Tommaso Sacquegna, Anna Zaniboni, Andrea Rubboli, Gaetano Procaccianti, Michela Crisci, Fabiola Maioli, Giorgia Arnone, Giuseppe Di Pasquale

314-322

15-12-2015

https://doi.org/10.4081/itjm.2015.468

2153

PDF: 1065

HTML: 1296
Effects of the availability of new oral anticoagulants in patients with non-valvular atrial fibrillation in the real world: the NAIF study

Francesco Ventrella, Franco Mastroianni, Sergio Cappello, Luigi Iamele, Samantha Errico, Massimo Errico

176-183

06-07-2016

https://doi.org/10.4081/itjm.2016.715

1690

PDF: 1070

HTML: 356
The incidence of bleeding in patients with nonvalvular atrial fibrillation using anticoagulants: a real-world report with the biggest Vietnamese data

Bui The Dung, Cao Ngoc Mai Han, Tran Hoa, Nguyen Thanh Hien

17-02-2025

https://doi.org/10.4081/itjm.2025.1807

2406

PDF: 566

HTML: 1
Mean platelet volume as diagnostic and therapeutic marker of risk and prognosis of heart disease

Henshaw Uchechi Okoroiwu, Christopher Ogar Ogar

10-14

11-01-2018

https://doi.org/10.4081/itjm.2018.918

2095

PDF: 949

HTML: 702
Cryptogenic stroke

Michele Stornello, Roberto Cappellani, Giuseppe Micieli, Simona Sacco, Stefano Spolveri, Roberto Sterzi, Danilo Toni, Antonio Carolei

185-194

30-09-2016

https://doi.org/10.4081/itjm.2016.682

2109

PDF: 1308

HTML: 614
Consensus document ANMCO/FADOI/SIAARTI/SIC/SIMG/SIMI/SIMEU: The clinical-diagnostic and therapeutic pathway of patients with acute heart failure in the Emergency Department

Mariavittoria Vescovo

247-276

28-11-2019

https://doi.org/10.4081/itjm.2019.1230

1909

PDF: 1021

HTML: 142
Cryptogenic strokes and embolic strokes of unknown source: lights and shadows of a new construct

Marco Masina

171-174

30-09-2016

https://doi.org/10.4081/itjm.2016.720

1593

PDF: 1110

HTML: 654
Heart failure in real world

Claudio Giumelli, Azio Reverzani, Riccardo Volpi, Giuseppe Chesi

356-361

05-10-2015

https://doi.org/10.4081/itjm.2015.550

1954

PDF: 1008

HTML: 1321
Direct oral anticoagulants for secondary prevention in patients with non-valvular atrial fibrillation

Luca Masotti, Mario Di Napoli, Walter Ageno, Davide Imberti, Cecilia Becattini, Maurizio Paciaroni, Daniel Augustin Godoy, Roberto Cappelli, Giancarlo Landini, Grazia Panigada, Ido Iori, Domenico Prisco, Giancarlo Agnelli

8-21

24-12-2013

https://doi.org/10.4081/itjm.2013.s8.8

1542

PDF: 1063
Pregnancy and heart disease: what Internists should know

Riccardo Gerloni, Domenico Panuccio

288-304

11-09-2017

https://doi.org/10.4081/itjm.2017.815

1685

PDF: 859

HTML: 285
Efficacy and safety of new oral anticoagulants compared with warfarin in cardioembolic prophylaxis of patients with non valvular atrial fibrillation. More lights than shadows

Luca Masotti, Mario Di Napoli, Walter Ageno, Davide Imberti, Daniel Godoy, Grazia Panigada, NiccolÃ² Napoli, Giancarlo Landini, Roberto Cappelli, Ido Iori, Domenico Prisco, Giancarlo Agnelli

153-169

23-10-2012

https://doi.org/10.4081/itjm.2012.153

1883

PDF: 2299
Antiarrhythmic or time bomb? A severe iatrogenic bradyarrhythmia

S. Matheou, A. Reverzani, F. Dall'Orto, G. Gambarati, G. Chesi

63-64

03-05-2013

https://doi.org/10.4081/itjm.2007.3.63

1100

PDF: 1602
Embolic stroke of undetermined source: a retrospective analysis from an Italian Stroke Unit

Marco Masina, Annalena Cicognani, Carla Lofiego, Simona Malservisi, Riccardo Parlangeli, Alessandro Lombardi

202-206

30-09-2016

https://doi.org/10.4081/itjm.2016.690

1868

PDF: 1045

HTML: 817
ORAL COMMUNICATION | Rhythm control strategy and outcomes in very elderly atrial fibrillation patients: an analysis of the nationwide Italian START registry

D. Menichelli, G. Gazzaniga, D. Poli, G. Di Carlo, E. Antonucci, G. Palareti, P. Pignatelli, D. Pastori

22-05-2026

https://doi.org/10.4081/itjm.2026.2565

177

PDF: 113
Management of syncope: from evidence to clinical practice

Tiziana M. Attardo, Immacolata Ambrosino, Elena Magnani, Nathan Artom, Nicola Battino, Deasy Cervo, Massimiliano Chiuch, Mariella Frualdo, Miriam Gino, Federico Pasin, Carlo Zaninetti

23-36

17-06-2016

https://doi.org/10.4081/itjm.2016.732

2192

PDF: 1437

HTML: 1434

1 - 16 of 16 items

Search

Search Results

Sex-gender and atrial fibrillation treatment in the AntiThrombotic Agents in Atrial Fibrillation (ATA-AF) study

Old and new oral anticoagulants for secondary stroke prevention in atrial fibrillation

Effects of the availability of new oral anticoagulants in patients with non-valvular atrial fibrillation in the real world: the NAIF study

The incidence of bleeding in patients with nonvalvular atrial fibrillation using anticoagulants: a real-world report with the biggest Vietnamese data

Mean platelet volume as diagnostic and therapeutic marker of risk and prognosis of heart disease

Cryptogenic stroke

Consensus document ANMCO/FADOI/SIAARTI/SIC/SIMG/SIMI/SIMEU: The clinical-diagnostic and therapeutic pathway of patients with acute heart failure in the Emergency Department

Cryptogenic strokes and embolic strokes of unknown source: lights and shadows of a new construct

Heart failure in real world

Direct oral anticoagulants for secondary prevention in patients with non-valvular atrial fibrillation

Pregnancy and heart disease: what Internists should know

Efficacy and safety of new oral anticoagulants compared with warfarin in cardioembolic prophylaxis of patients with non valvular atrial fibrillation. More lights than shadows

Antiarrhythmic or time bomb? A severe iatrogenic bradyarrhythmia

Embolic stroke of undetermined source: a retrospective analysis from an Italian Stroke Unit

ORAL COMMUNICATION | Rhythm control strategy and outcomes in very elderly atrial fibrillation patients: an analysis of the nationwide Italian START registry

Management of syncope: from evidence to clinical practice

authors

reviewers

indexing

Keywords